The Afstyla market is witnessing steady growth over the forecast period, supported by growth in prophylactic treatment adoption, rising pediatric diagnosis rates.
Read More
The Afrezza market is witnessing steady growth over the forecast period, supported by rising type 2 diabetes population, growing acceptance of inhalation drug delivery.
Read More
The Afluria Quadrivalent market is witnessing steady growth over the forecast period, supported by demand for broader strain coverage, increasing healthcare worker immunization.
Read More
The Afluria market is witnessing steady growth over the forecast period, supported by growth in preventive healthcare awareness, increasing vaccination coverage targets.
Read More
The ADZYNMA market is witnessing steady growth over the forecast period, supported by growth in rare disease awareness programs, improved affordability of targeted therapies.
Read More
The Adynovate (Adynovi) market is witnessing steady growth over the forecast period, supported by demand for reduced infusion frequency, increasing adoption of long-acting biologics.
Read More
The Advate market is witnessing steady growth over the forecast period, supported by growth in long-term prophylaxis adoption, increasing patient preference for home care.
Read More
The Aduhelm market is witnessing steady growth over the forecast period, supported by growth in alzheimer patient pool, demand for early intervention therapies.
Read More
The Adstiladrin market is witnessing steady growth over the forecast period, supported by expansion of gene therapy pipelines, increasing oncology precision medicine adoption.
Read More
The Admelog market is witnessing steady growth over the forecast period, supported by increasing biosimilar penetration, government cost containment policies.
Read More